Related references
Note: Only part of the references are listed.AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma
Helene Tuft Stavnes et al.
VIRCHOWS ARCHIV (2013)
Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
Casina W. S. Kan et al.
BMC CANCER (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
ZNF385B and VEGFA Are Strongly Differentially Expressed in Serous Ovarian Carcinomas and Correlate with Survival
Bente Vilming Elgaaen et al.
PLOS ONE (2012)
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
Stefano Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
Jaime Prat
VIRCHOWS ARCHIV (2012)
Posttranscriptional Upregulation by MicroRNAs
Shobha Vasudevan
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
Epithelial mesenchymal transition in ovarian carcinoma
Ben Davidson et al.
FRONTIERS IN ONCOLOGY (2012)
The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Susanna Leskelae et al.
ENDOCRINE-RELATED CANCER (2011)
Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
Michael S. Anglesio et al.
GYNECOLOGIC ONCOLOGY (2011)
A microRNA survival signature (MiSS) for advanced ovarian cancer
Karin K. Shih et al.
GYNECOLOGIC ONCOLOGY (2011)
The Origin of Ovarian Carcinomas: A Unifying Hypothesis
Nelly Auersperg
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2011)
miRNA profiling along tumour progression in ovarian carcinoma
Olga Vaksman et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
Sergio Marchini et al.
LANCET ONCOLOGY (2011)
Gene silencing by microRNAs: contributions of translational repression and mRNA decay
Eric Huntzinger et al.
NATURE REVIEWS GENETICS (2011)
MicroRNAs and Their Role in Gynecological Tumors
Anna Torres et al.
MEDICINAL RESEARCH REVIEWS (2011)
Efficient in vivo microRNA targeting of liver metastasis
C. Huynh et al.
ONCOGENE (2011)
Posttranscriptional activation of gene expression in Xenopus laevis oocytes by microRNA-protein complexes (microRNPs)
Richard D. Mortensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours
Tae Heon Kim et al.
HISTOPATHOLOGY (2010)
The role of microRNAs in ovarian cancer initiation and progression
Shuang-Di Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
POLD2 and KSP37 (FGFBP2) Correlate Strongly with Histology, Stage and Outcome in Ovarian Carcinomas
Bente Vilming Elgaaen et al.
PLOS ONE (2010)
MicroRNA-200 Family Members Differentially Regulate Morphological Plasticity and Mode of Melanoma Cell Invasion
Ilan Elson-Schwab et al.
PLOS ONE (2010)
Ovarian Low-grade and High-grade Serous Carcinoma Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems
Russell Vang et al.
ADVANCES IN ANATOMIC PATHOLOGY (2009)
A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells
Oliver A. Kent et al.
CANCER BIOLOGY & THERAPY (2009)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression
Gregory J. Hurteau et al.
CELL CYCLE (2009)
MicroRNAs: tools for cancer diagnostics
T. Paranjape et al.
GUT (2009)
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
Xiaoxia Hu et al.
GYNECOLOGIC ONCOLOGY (2009)
MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy
Todd Boren et al.
GYNECOLOGIC ONCOLOGY (2009)
Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
Ram Eitan et al.
GYNECOLOGIC ONCOLOGY (2009)
Allele Variants in Functional MicroRNA Target Sites of the Neurotrophin-3 Receptor Gene (NTRK3) as Susceptibility Factors for Anxiety Disorders
Margarita Muinos-Gimeno et al.
HUMAN MUTATION (2009)
MicroRNAs in colorectal cancer: translation of molecular biology into clinical application
Ondrej Slaby et al.
MOLECULAR CANCER (2009)
MicroRNA-Mediated Inhibition of Prostate-Derived Ets Factor Messenger RNA Translation Affects Prostate-Derived Ets Factor Regulatory Networks in Human Breast Cancer
Victoria J. Findlay et al.
CANCER RESEARCH (2008)
MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
Nuo Yang et al.
CANCER RESEARCH (2008)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
MicroRNA expression profiles in serous ovarian carcinoma
Eun Ji Nam et al.
CLINICAL CANCER RESEARCH (2008)
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
Ann K. Folkins et al.
GYNECOLOGIC ONCOLOGY (2008)
Serous carcinogenesis in the fallopian tube: A descriptive classification
Elke Jarboe et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer
Neetu Dahiya et al.
PLOS ONE (2008)
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
Lin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Switching from repression to activation: MicroRNAs can up-regulate translation
Shobha Vasudevan et al.
SCIENCE (2007)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship
David W. Kindelberger et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome
F Medeiros et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Ovarian tumorigenesis - A proposed model based on morphological and molecular genetic analysis
IM Shih et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
JMJ Piek et al.
JOURNAL OF PATHOLOGY (2001)
Share Paper
